See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2017_Provectus_Biopharmaceuticals_INC.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -172376} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,826,300 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,241,467 |
| 2 | PropertyPlantAndEquipmentNet | 72,033 |
| 3 | remainder_Assets | 1,471,210 |
| 4 | LiabilitiesCurrent | 2,141,826 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 436,248 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -23,991,022 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,611,010 |
| 1 | Liabilities | 2,141,826 |
| 2 | Expenses | 436,248 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,469,184 |
| 5 | NetIncome | -24,427,270 |
| 6 | ComprehensiveNetIncome | -24,427,270 |
| 7 | BaseVar | 16,090,053 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.35 |
| 9 | EconomicCapitalRatio | 0.310 |
Edgar->Model Mapping
Feature Distribution
Change over Time
